Literature DB >> 22418431

Pulmonary surfactant protein A protects lung epithelium from cytotoxicity of human β-defensin 3.

Atsushi Saito1, Shigeru Ariki, Hitoshi Sohma, Chiaki Nishitani, Kanako Inoue, Nobutaka Ebata, Motoko Takahashi, Yoshihiro Hasegawa, Koji Kuronuma, Hiroki Takahashi, Yoshio Kuroki.   

Abstract

Defensins are important molecules in the innate immune system that eliminate infectious microbes. They also exhibit cytotoxicity against host cells in higher concentrations. The mechanisms by which hosts protect their own cells from cytotoxicity of defensins have been poorly understood. We found that the cytotoxicity of human β-defensin 3 (hBD3) against lung epithelial cells was dose-dependently attenuated by pulmonary surfactant protein A (SP-A), a collectin implicated in host defense and regulation of inflammatory responses in the lung. The direct interaction between SP-A and hBD3 may be an important factor in decreasing this cytotoxicity because preincubation of epithelial cells with SP-A did not affect the cytotoxicity. Consistent with in vitro analysis, intratracheal administration of hBD3 to SP-A(-/-) mice resulted in more severe tissue damage compared with that in WT mice. These data indicate that SP-A protects lung epithelium from tissue injury caused by hBD3. Furthermore, we found that the functional region of SP-A lies within Tyr(161)-Lys(201). Synthetic peptide corresponding to this region, tentatively called SP-A Y161-G200, also inhibited cytotoxicity of hBD3 in a dose-dependent manner. The SP-A Y161-G200 is a candidate as a therapeutic reagent that prevents tissue injury during inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418431      PMCID: PMC3340224          DOI: 10.1074/jbc.M111.308056

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Mechanisms of antimicrobial peptide action and resistance.

Authors:  Michael R Yeaman; Nannette Y Yount
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

Review 2.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

3.  In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes.

Authors:  A Lichtenstein; T Ganz; M E Selsted; R I Lehrer
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

4.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

5.  Induction of human β-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-κB, and AP-1.

Authors:  Stefanie Scharf; Stefan Hippenstiel; Antje Flieger; Norbert Suttorp; Philippe Dje N'Guessan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-12       Impact factor: 5.464

6.  Effect of hydroxylation and N187-linked glycosylation on molecular and functional properties of recombinant human surfactant protein A.

Authors:  I García-Verdugo; F Sánchez-Barbero; F U Bosch; W Steinhilber; C Casals
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

7.  Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A.

Authors:  James F Head; Tanya R Mealy; Francis X McCormack; Barbara A Seaton
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

8.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.

Authors:  Miguel E Quiñones-Mateu; Michael M Lederman; Zhimin Feng; Bikram Chakraborty; Jan Weber; Hector R Rangel; Michael L Marotta; Muneer Mirza; Bin Jiang; Patti Kiser; Kathy Medvik; Scott F Sieg; Aaron Weinberg
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

9.  Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro.

Authors:  Jamil Aarbiou; Renate M Verhoosel; Sandra Van Wetering; Willem I De Boer; J Han J M Van Krieken; Sergey V Litvinov; Klaus F Rabe; Pieter S Hiemstra
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07-18       Impact factor: 6.914

10.  Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity.

Authors:  A K Lichtenstein; T Ganz; T M Nguyen; M E Selsted; R I Lehrer
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

View more
  5 in total

1.  Cytotoxicity of HBD3 for dendritic cells, normal human epidermal keratinocytes, hTERT keratinocytes, and primary oral gingival epithelial keratinocytes in cell culture conditions.

Authors:  Nattawut Leelakanok; Carol L Fischer; Amber M Bates; Janet M Guthmiller; Georgia K Johnson; Aliasger K Salem; Kim A Brogden; Nicole K Brogden
Journal:  Toxicol Lett       Date:  2015-09-11       Impact factor: 4.372

2.  Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.

Authors:  Yoshihiro Hasegawa; Motoko Takahashi; Shigeru Ariki; Atsushi Saito; Yasuaki Uehara; Rina Takamiya; Koji Kuronuma; Hirofumi Chiba; Yuji Sakuma; Hiroki Takahashi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

Review 3.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

4.  The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro.

Authors:  Lidia de Tapia; Belén García-Fojeda; Nina Kronqvist; Jan Johansson; Cristina Casals
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

5.  Mechanism of Anti-Inflammatory Activity of TLR4-Interacting SPA4 Peptide.

Authors:  Shanjana Awasthi; Gaurav Kumar; Vijay Ramani; Vibhudutta Awasthi; Karla K Rodgers; Jun Xie; Jacob Beierle; Gertrude Kyere-Davies; Bhupinder Singh; Negar Rahman; Asif Alam Chowdhury; Neha Chataut
Journal:  Immunohorizons       Date:  2021-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.